OptimizeRx Corp Quarterly General and Administrative Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
OptimizeRx Corp quarterly/annual General and Administrative Expense history and growth rate from Q2 2011 to Q3 2024.
  • OptimizeRx Corp General and Administrative Expense for the quarter ending September 30, 2024 was $13.4M, a 4.18% increase year-over-year.
  • OptimizeRx Corp annual General and Administrative Expense for 2013 was $288K, a 7% increase from 2012.
  • OptimizeRx Corp annual General and Administrative Expense for 2012 was $269K, a 39.6% decline from 2011.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.4M +$539K +4.18% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $14.4M +$2.17M +17.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 $16.2M +$2.13M +15.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q3 2023 $12.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $12.2M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 $14M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2014 $159K $89.3K -$130K -59.2% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $288K -$81.7K -$154K -213% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-31
Q3 2013 $442K $94.8K +$31.5K +49.9% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $411K $56.5K -$645 -1.13% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $411K $219K +$142K +184% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $269K $72.1K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $63.2K -$69.6K -52.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $57.1K -$43.8K -43.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $77.1K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $133K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $101K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.